OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,405 | -2.1% | 466 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,456 | +87.6% | 466 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $1,309 | -56.4% | 466 | -38.2% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | -25.0% | 754 | -29.9% | 0.00% | -33.3% |
| Q2 2022 | $4,000 | -20.0% | 1,075 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -44.4% | 1,075 | -14.5% | 0.00% | -40.0% |
| Q4 2021 | $9,000 | -30.8% | 1,257 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $13,000 | -27.8% | 1,257 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $18,000 | -43.8% | 1,257 | -36.4% | 0.01% | -47.6% |
| Q1 2021 | $32,000 | 0.0% | 1,976 | +26.6% | 0.02% | 0.0% |
| Q4 2020 | $32,000 | – | 1,561 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |